Stefan Schmiedel

Dr. Stefan Schmiedel is a Professor at the I. Medical Clinic and Polyclinic within the Faculty of Medicine at Universitätsklinikum Hamburg-Eppendorf. With an extensive publication record spanning from 2007 to 2025, he has established himself as a leading researcher in infectious diseases and tropical medicine. His work demonstrates consistent collaboration with major research groups at the university hospital, particularly within the Immunology, Immunity, Infection (C3i) research area.

Dr. Schmiedel's research interests focus on emerging infectious diseases, tropical medicine, and clinical microbiology. His work spans viral infections (including mpox, Ebola, and SARS-CoV-2), bacterial diseases (particularly tuberculosis and listeriosis), and parasitic infections (such as malaria and leishmaniasis). He has made significant contributions to understanding disease pathogenesis, developing diagnostic approaches, and evaluating treatment protocols for complex infectious cases. His research often bridges clinical practice with laboratory investigation, emphasizing translational medicine.

Analysis of his recent publications reveals a strong focus on emerging infectious disease outbreaks, particularly mpox and COVID-19 variants, alongside continued work on classic tropical diseases and drug-resistant infections. His research increasingly incorporates advanced diagnostic techniques including molecular methods and imaging approaches. The work demonstrates a consistent pattern of clinical case investigation combined with broader epidemiological analysis, often with implications for treatment guidelines and public health responses.

Dr. Schmiedel has been actively involved in clinical research and outbreak investigations, contributing to German and international responses to infectious disease threats. His work with immunocompromised patients and those with complex comorbidities highlights his expertise in managing challenging clinical scenarios. While specific grant information isn't detailed in the available publications, his extensive collaborative network suggests significant research funding support for his work.

His research appears to be conducted within the broader framework of the Hamburg Center of Neuroscience and the Immunology, Immunity, Infection (C3i) research areas at UKE, suggesting integration with larger institutional research initiatives focused on host-pathogen interactions and immune responses to infection.